1. Introduction
cancers
CANCERS
Radionuclide therapy plays an increasingly important role in treating a range of cancers in the last few years; we have witnessed unprecedented advances in the field of nuclear medicine (Patients receiving 131I treatment after thyroidectomy exposes to the corresponding radiation to others, due to the accumulation of radionuclides in the body. During the period of taking radioactive drugs, patients are equivalent to a mobile radioactive source, which causes certain radiation damage to medical staff, family members, and other patients, making it necessary to take isolation and protective measures (Recently, mobile robots have been produced, and medical staff hopes the robots can be used in isolation wards. The application of mobile robots is helpful to collect patients' vital signs and radiation dose rate information and improves the efficiency of the nursing management level for patients. Nowadays, the mobile robot has passed the registration inspection of the Shanghai Medical Device Testing Institute and obtained the test report (No. ZC 2017-789, ZC 2017-790). However, there is no clinical trial to verify the effectiveness and safety of mobile robots.The objective of this randomized clinical trial was to evaluate the effectiveness and safety of mobile robots in providing vital signs and radiation dose rate service for patients receiving Iodine-131 radiotherapy in isolation wards.